主要業績:

• 抗菌薬TDMガイドライン2016におけるバンコマイシン初期投与設計に対するeGFRを用いたノモグラムの検証－軽度から中等度の腎機能低下患者における検討－（増田, 毎熊, 広本, 春木, 杉山, 手嶋）　　TDM研究, 34（4）132-136 (2017).
• 腎機能に着目したバンコマイシンTDM解析ソフトの特性に基づいた初期投与設計（春木, 広本, 岡, 春木, 増田, 杉山, 手嶋、近藤, 毎熊）就実大学薬学雑誌1, 47-54 (2016).
• 薬剤師から見た医師主導バンコマイシン初期投与設計の評価（増田, 毎熊, 広本, 春木, 杉山, 近藤, 手嶋）就実大学薬学雑誌1, 62-70 (2016).
• 療養病棟における入院9週目以降での薬剤師の介入効果-病棟薬剤業務における処方提案-（渡辺, 毎熊, 難波, 山崎, 高取,廣本, 賀勢, 今井, 安藤, 手嶋）　　医療薬学42(8), 551-557(2016)
• Impact of pharmacist intervention on preventing nephrotoxicity from vancomaycin. (N. Masuda, T. Maiguma, A. Komoto, Y. Haruki, T. Sugiyama, S. Kondo, D. Teshima )　　International Journal of clinical pharmacology and therapeutics, 53(4), 284-291(2015).

その他の業績はresearchmapの研究者情報へ

主要業績:

• Suzuki-Nishimura T:　Clinical Trials and GCP. J.Health Sci. 56(3), 231-238, 2010.
• 西村(鈴木)多美子: 医薬品の信頼性と安全性の確保とGood Clinical Practice, 信頼性, 33, 68-75, 2011.（日本信頼性学会2011年度優秀記事コラム賞受賞）
• Suzuki-Nishimura T, Hosokawa T, Seno M, Kato Y: Inhibitory effects of GlcNAc polymers on histamine release from mast cells by Datura stramonium agglutinin, The Shujitsu university journal of pharmaceutical sciences, 4, 10-15, 2017.
• 田中伸枝，西村（鈴木）多美子: 新たに承認された抗体医薬品の妊婦等に対するリスクベネフィットバランス評価,　レギュラトリーサイエンス学会誌, 8(1), 5-18, 2018.
• 西村（鈴木）多美子: 医薬品GLP調査の国際的必要性, 日本薬理学会編,『創薬研究のストラテジー　下』, 金芳堂, 2011.

主要業績:

• 見尾光庸「抗炎症薬，抗リウマチ薬，痛風治療薬」，佐藤進編『新薬理学テキスト〔第3版〕』，廣川書店（2011）
• 見尾光庸，小駒益弘，福井裕行，竹田篤「ナノ粒子による炎症性伝達物質吸着を利用した炎症制御の研究」，『ケミカルエンジニヤリング』，第55巻(2010)
• Satomi A, Mio M, Tanaka K, Kogoma M “Silica nano powder formation using ICP plasma and evaluation of its adsorption ability for biotic substances”, J Photopolymer Sci Tech, 21 (2008)
• Takatori S, Zamami Y, Yabumae N, Hanafusa N, Mio M, Egawa T, Kawasaki H “Pioglitazone opposes neurogenic vascular dysfunction associated with chronic hyperinsulinaemia”, Br J Pharmacol, 153 (2008)
• Zamami Y, Takatori S, Yamawaki K, Miyashita S, Mio M, Kitamura Y, Kawasaki H. “Acute hyperglycemia and hyperinsulinemia enhance adrenergic vasoconstriction and decrease calcitonin gene-related peptide-containing nerve-mediated vasodilation in pithed rats”, Hypertens Res, 31 (2008)

その他の業績はresearchmapの研究者情報へ

主要業績:

• Okuda J, Kiriyama M, Suzaki E, Kataoka K, Nishibuchi M, Nakai T, “Characterization of proteins secreted from a type III secretion system of?Edwardsiella tarda?and their roles in macrophage infection”,?Disease of Aquatic Organisms, 84 (2009).?
• Suzaki E, Nomura R, Horio T, Mineyuki Y, Kataoka K, “γ-tubulin-like molecules in the mouse duodenal epithelium”, Histochemistry and Cell Biology, 128 (2007).?
• Kataoka K, Suzaki E, Ajima N, “The Hoshino wooden skeleton, the first wooden model of a human skeleton, made during the Edo era in Japan”, Anatomical Science International, 82 (2007).?
• Suzaki E, Wang G, Cao G, Wang H-Q, Englander EW, Greeley Jr. GH, “Apelin cells in the rat stomach”, Regulatory Peptides, 129 (2005).?
• Suzaki E, Suzaki T, Kataoka K, “Use of Taxol and collagenase for better three-dimensional visualization of microtubules in the enterocyte and Brunner’s gland cell, with special reference to their relation to the Golgi apparatus”, Journal of Electron Microscopy, 53 (2004)

その他の業績はresearchmapの研究者情報へ

主要業績:

• 抗てんかん薬TDM標準化ガイドライン 2018, 編集:一般社団法人 日本TDM学会, 分担，末丸克矢：ゾニサミド, ラモトリギン, 金原出版 (2018年)
• 新しい疾患薬理学,編集: 岩崎克典/徳山尚吾, 分担，末丸克矢：7章 代謝系・内分泌系の疾患と治療薬; A　糖尿病・代謝系内科領域の疾患に用いる薬物 (1糖尿病, 2脂質異常症, 3高尿酸血症・痛風) 南江堂 (2018年).
• Suemaru K, Yoshikawa M, Tanaka A, Araki H, Aso H, Watanabe M. Anticonvulsant effects of acetaminophen in mice. Comparison with the effects of nonsteroidal anti-inflammatory drugs. Epilepsy Res. 140: 22-28 (2018).
• Suemaru K, Yoshikawa M, Aso H, Watanabe M. TRPV1 mediates the anticonvulsant effects of acetaminophen in mice. Epilepsy Res. 145: 153-159 (2018).
• Suemaru K, Yoshikawa M, Aso H, Watanabe M. Environmental enrichment alleviates cognitive and behavioral impairments in EL mice. Epilepsy Behav. 85: 227-233 (2018).
• Takechi K, Suemaru K, Kiyoi T, Tanaka A, Araki H. The α4β2 nicotinic acetylcholine receptor modulates autism-like behavioral and motor abnormalities in pentylenetetrazol-kindled mice. Eur J Pharmacol. 775: 57-66 (2016).
• Tasaka Y, Yasunaga D, Kiyoi T, Tanaka M, Tanaka A, Suemaru K, Araki H. Involvement of stimulation of α7 nicotinic acetylcholine receptors in the suppressive effect of tropisetron on dextran sulfate sodium-induced colitis in mice. J Pharmacol Sci. 127: 275-283 (2015).

主要業績:

• Gao Y, et al. “Phagocytosis of advanced glycation end products (AGEs) in macrophages induces cell apoptosis.” Oxid Med Cell Longev, doi: 10.1155/2017/8419035. (2018)
• Kuroda K, et al. “Decrease in histidine-rich glycoprotein as a novel biomarker to predict sepsis among systemic inflammatory response syndrome” Critical Care Medicine, 46: 570-576 (2018)
• Watanabe M, et al. “ Advanced glycation end products attenuate the function of tumor necrosis factor-like weak inducer of apoptosis to regulate the inflammatory response” Mol Cell Biochem, 434: 153-162 (2017)
• Fu L, et al. “Therapeutic effects of anti-HMGB1 monoclonal antibody on pilocarpine- induced status epilepticus in mice” Sci Rep, 7: 1179. doi: 10.1038/s41598-017- 01325-y. (2017)
• Wang D, et al. “Anti-high mobility group box-1 (HMGB1) antibody inhibits hemorrhage- induced brain injury and improved neurological deficits in rats” Sci Rep, 7: 46243. doi: 10.1038/srep46243. (2017)

その他の業績はresearchmapの研究者情報へ

主要業績:

• Hisatsune J, Hagiya H, Shiota S, Sugai M. Complete Genome Sequence of Systemically Disseminated Sequence Type 8 Staphylococcal Cassette Chromosome mec Type IVl Community-Acquired Methicillin-Resistant Staphylococcus aureus. M. Genome Announc. 2017 Aug 31;5(35)(2017)
• 和田朋子, 山田陽一, 近藤祥代, 杉山哲大, 塩田澄子.　臨床現場における市中感染型 MRSA の増加とバイオフィルム形成能の関連　Relation between the increase of the isolation number of Community-Acquired MRSA and their biofilm formation. 就実大学薬学雑誌第4巻p16-22（2017
• Hagiya H, Haruki Y, Uchida T, Wada T, Shiota S, Ishida T, Ogawa H, Murase T, Otsuka F. Emergence of Daptomycin-Resistant Staphylococcus aureus during Treatment. Intern Med.;55(1):73-78.（2016）
• Hagiya H, Shiota S, Sugiyama W, Otsuka F. Postpartum breast abscess caused by community-acquired methicillin-resistant Staphylococcus aureus in Japan.　 Breastfeed Med., 9(1):45-46. (2014)
• Hagiya H, Hisatsune J, Kojima T, Shiota S, Naito H, Hagioka S, Morimoto N, Otsuka F, Sugai, M. Comprehensive analysis of systemically disseminated ST8/non-USA300 type community-acquired methicillin-resistant Staphylococcus aureus infection. Intern Med., 53(8):907-912. (2014)

その他の業績はresearchmapの研究者情報へ

主要業績:

• Kaji H., Inukai Y., Maiguma T., Ono H., Teshima D., Hiramoto K. and Makino K, “Radical scavenging activity of bisbenzylisoquinoline alkaloids and traditional prophylactics against chemotherapy-induced oral mucositi”,J ClinPharmTher., 34(2008)
• Toorisaka E., Hashida M., Kamiya N., Ono H., Kokazu Y. and Goto M.,“An enteric-coated dry emulsion formulation for oral insulin delivery”,J Control Release,107(1), (2005)
• Toorisaka E., Ono H., Arimori K., Kamiya N. and Goto M.,“Hypoglycemic effect of surfactant-coated insulin　solubilized in a novel solid-in-oil-in-water (S/O/W) emulsion”, Int. J. Pharm., 252（2003）

主要業績:

• Niwa T, Yanai M, Matsumoto M, Shizuku M. "Effect of cytochrome P450 (CYP) 2D6 genetic polymorphism on the inhibitory action of antidepressants on CYP2D6-mediated dopamine formation fromp-tyramine". J Pharm Pharm Sci. 21, 135-142 (2018).
• Niwa T, Shizuku M, Yamano K., "Effect of genetic polymorphism on the inhibition of dopamine formation from?p-tyramine catalyzed by brain cytochrome P450 2D6", Arch Biochem Biophys, 620, 23-27 (2017)..
• Niwa T, Hata T, "The effect of genetic polymorphism on the inhibition of azole antifungal agents against CYP2C9-mediated metabolism", J Pharm Sci, 105, 1345-1348 (2016).
• Niwa T, Imagawa Y. "Substrate specificity of human cytochrome P450 (CYP) 2C subfamily and effect of azole Antifungal agents on CYP2C8", J Pharm Pharm Sci, 19, 423-429 (2016).
• Niwa T, Murayama N, Imagawa Y, Yamazaki H, "Regioselective hydroxylation of steroid hormones by human cytochromes P450", Drug Metab Rev, 47, 89-110 (2015).

その他の業績はresearchmapの研究者情報へ

主要業績:

• Sayuri Sakamoto, Etsuko Suzaki, Osamu Hiraoka＊ Expression and purification of EF-hand endoplasmic reticulum-resident calcium-binding protein from Plasmodium falciparum using the E. coli Lemo21 (DE3) strain SHUJITSU RONSO No.47 PP.289-297 (2018)
• Osamu Hiraoka, Seita Ando, Yuhki Suemune, Kenichi Shimada, Masao Akamatsu,Scientific study of ease of removal of tablets from PTP sheet J Community Pharm Pharm Sci. Vol.9 No.2, 219-226 (2017)
• Osamu Hiraoka, Takuya Terai, Moe Kohno, Shigeru Sugiyama. Genetically engineered monomeric streptavidin for designing a new detection systems based on monovalent biotin interaction. The Shujitsu University Journal of Pharmaceutical Sciences Volume 3, 16-26 (2016)
• Sugiyama S., Shimizu N., Kakinouchi K., Hiraoka O., Matsumura H., Yoshikawa H.Y., Takahashi Y., Maruyama M., Yoshimura M., Adachi H., Takano K., Murakami S., Inoue T., Murata M. and Mori Y. Development of protein seed crystals reinforced with high-strength hydrogels. CrystEngComm. 17, 8064-8071 (2015)
• Hiraoka O, Hiraoka K.?A Study of Pharmacists’ Job Satisfaction, Organizational Commitment, and Social Support in Organizational Management.?The Shujitsu University Journal of Pharmaceutical Sciences Volume 2, 63-67 (2015)

その他の業績はresearchmapの研究者情報へ

主要業績:

• 國府團，五味田裕編『薬剤師・看護師・医薬系学生のための臨床医薬略語集』，医歯薬出版，2010〔分担執筆〕
• 江川孝，谷口律子，柴田隆司，前田純子，小野浩重，島田憲一，五味田裕「PBL型コミュニケーション演習における模擬患者の積極的活用と演習内容の評価」，『医療薬学』第36巻（2010）
• Tadatsugu Tarumi, Azusa Mikami, Kenichi Shimada Chiaki Kamei,”Participation of the Cholinergic System in Ameliorating Effect of Vasopressin Fragment by Group I Metabotropic Glutamate Receptor Blockade”,J Pharmacol Sci.,3(2008)
• 塚田由美子，見市昇，荒木雅史，吉野公博，北浦道夫，木口亨，木村圭吾，善家雄吉，島田憲一 他「ノロウィルスアウトブレイクに対する組織的な取り組み」，『香川労災病院雑誌』第14巻（2008）
• 木口亨，各務慎一，滝本秀隆，島田憲一　他B細胞性前リンパ球性白血病の1例」，『香川県内科医会誌』第43巻（2007）

主要業績:

• 増田, 毎熊, 広本, 春木, 杉山, 手嶋. 抗菌薬TDMガイドライン2016におけるバンコマイシン初期投与設計に対するeGFRを用いたノモグラムの検証 －軽度から中等度の腎機能低下患者における検討－. TDM研究, 34, 132-136 (2017)
• N. Masuda, T. Maiguma, A. Komoto, Y. Haruki, T. Sugiyama, S. Kondo, D. Teshima. Impact of pharmacist intervention on preventing nephrotoxicity from vancomaycin. Int J Clin Pharmacol Ther. 53(4), 284-291 (2015)
• Maiguma T, Kaji H, Makino K, Teshima D. Protective effects of amifostine and cyclooxygenase inhibitor against normal human epidermal keratinocyte toxicity induced by methotrexate and 5-fluorouracil. Basic Clin Pharmacol Toxicol. 105, 1-9 (2009)
• Maiguma T, Hayashi Y, Ueshima S, Kaji H, Egawa T, Chayama K, Morishima T, Kitamura Y, Sendo T, Gomita Y, Teshima D. Relationship between oral mucositis and high-dose methotrexate therapy in pediatric acute lymphoblastic leukemia. Int J Clin Pharmacol Ther. 46(11), 584-590 (2008)
• Maiguma T, Fujisaki K, Itoh Y, Makino K, Teshima D, Takahashi-Yanaga F, Sasaguri T, Oishi R, Cell-specific degeneration induced by fibrates in human embryonal rhabdomyosarcoma cells. Naunyn-Schmideberg’ s Arch　Pharmacol. 367, 289-296 (2003)

その他の業績はresearchmapの研究者情報へ

主要業績:

• Sun-Wada G.-H., Toyomura T., Murata Y., Yamamoto A., Futai M., and Wada Y. “The a3 isoform of V-ATPase regulates insulin secretion from pancreatic β-cells.”J. Cell Sci. 119 (2006)
• Toyomura T., Murata Y., Yamamoto A., Oka T., Sun-Wada G.-H., Wada Y., and Futai M.”From lysosomes to the plasma membrane: localization of vacuolar-type H+-ATPase with the a3 isoform during osteoclast differentiation.” J. Biol. Chem. 278 (2003)

その他の業績はresearchmapの研究者情報へ

主要業績:

• Kawakami T, He J, Morita H, Yokoyama K, Kaji H, Tanaka C, Suemori S, Tohyama K, Tohyama Y, “Rab27a is essential for the formation of neutrophil extracellular traps(NETS) in neutrophil-like differentiated HL60 cells” PLOS ONE. 9(1), e84704 (2014)
• Shinichi Watanabe; Katsuya Suemaru, PhD; Kenshi Takechi, PhD; Hiroaki Kaji, PhD; Kimie Imai, PhD; Hiroaki Araki, PhD, “Oral mucosal adhesive films containing royal jelly accelerate recovery from 5-fluorouracil-induced oral mucositis” Journal of Pharmacological Sciences, 121, 110-118 (2013)
• Tanaka K, Ogo H, Kaji H, Miyatake K, Tokudome E, Sonoda K, Ogawa N, Asanuma M. “Dipeptidyl compounds ameliorate the serum-deprivation-induced reduction in cell viability via the neurotrophin-activating effect in SH-SY5Y cells.” Neurol Res. Jul;34(6):619-22 (2012)
• C. Tanaka, H. Kaji, R. Hazama, K. Yokoyama, E. Kinoshita, T. Tsujioka, K. Tohyama, H. Yamamura, H. NIshio, Y. Tohyama, “Rab27b regulates c-kit expression by controlling the secretion of stem cell factor” Biochem. Biophys. Res. Commun., 419, 368-373(2012)
• K. Yokoyama, H. Kaji, J. He, C. Tanaka, R. Hazama, T. Kamigaki, Y. Ku, K. Tohyama, Y. Tohyama, “Rab27a negatively regulates phagocytosis by prolongation of the actin-coating stage around phagosomes“ J. Biol. Chem., 286, 5375-5382(2011)

主要業績:

• Watanabe M, Toyomura T, Wake H, Liu K, Teshigawara K, Takahashi H, Nishibori M, Mori S. Advanced Glycation End Products Attenuate the Function of Tumor Necrosis Factor-like Weak Inducer of Apoptosis to Regulate the Inflammatory Response. Mol Cell Biochem, Vol. 434, No. 1, pp. 153-162 (2017)
• Watanabe M, Fukuoka N, Takeuchi T, Yamaguchi K, Motoki T, Tanaka H, Kosaka S, Houchi H. Developing Population Pharmacokinetic Parameters for High-dose Methotrexate Therapy: Implication of Correlations among Developed Parameters for Individual Parameter Estimation Using the Bayesian Least-squares Method. Biol Pharm Bull, Vol. 37, No. 6, pp. 916-921 (2014)
• Watanabe M, Yamamoto T, Yamamoto A, Obana E, Niiyama K, Hada T, Ooie T, Kataoka M, Hori T, Houchi H, Shinohara Y. Differential effects of cold exposure on gene expression profiles in white versus brown adipose tissue. Appl Biochem Biotechnol, Vol. 165, No. 2, pp. 538-547 (2011)
• Watanabe M, Yamamoto T, Mori C, Okada N, Yamazaki N, Kajimoto K, Kataoka M, Shinohara Y. Cold-induced changes in gene expression in brown adipose tissue: implications for the activation of thermogenesis. Biol Pharm Bull, Vol. 31, No. 5, pp. 775-784 (2008)
• Watanabe M, Yamamoto T, Kakuhata R, Okada N, Kajimoto K, Yamazaki N, Kataoka M, Baba Y, Tamaki T, Shinohara Y. Synchronized changes in transcript levels of genes activating cold exposure-induced thermogenesis in brown adipose tissue of experimental animals. Biochim Biophys Acta, Vol. 1777, No. 1, pp. 104-112 (2008)

その他の業績はresearchmapの研究者情報へ

主要業績:

• Characterization of community acquired methicillin resistant Staphylococcus aureus (CA MRSA) with the high risk factors found from the toxigenic gene profile from clinical isolates, Y. Yamada, M. Ayama, M. Kobayashi, T. Wada, T. Kudo, T. Sugiyama, S. Shiota, The Shujitsu University journal of pharmaceutical sciences, vol. 6, p. 50-54, (2019)
• T. Wada, Y. Yamada, S. Kondo, T. Sugiyama, S. Shiota, Relation between the increase of the isolation number of Community-Acquired MRSA and their biofilm formation, The Shujitsu University journal of pharmaceutical sciences, vol.4, p.16-22, (2017)
• A. Tahira, S. Ishida, S. Shiota, Y. Yamada, Gene cloning and characterization of a novel multidrug efflux pump in Legionella pneumophila, The Shujitsu University journal of pharmaceutical sciences, vol. 4, p. 49-53, (2017)
• M. Matsui, K. Tanaka, N. Higashiguchi, H. Okawa, Y. Yamada, K. Tanaka, S. Taira, T. Aoyama, M. Takanishi, C. Natsume, Y. Takakura, N. Fujita, T. Hashimoto, T. Fujita, Protective and therapeutic effects of fucoxanthin against sunburn caused by UV irradiation, J. Pharm. Sci., vol. 132, p. 55-64, (2016)
• N. Suzuki, N. Ohtaguro, Y. Yoshida, M. Hirai, H. Matsuo, Y. Yamada*, N. Imamura, T. Tsuchiya, (*corresponding author) A Compound Inhibits Biofilm Formation of Staphylococcus aureus from Streptomyce, Biol. Pharm. Bull., vol. 38, p. 889-92, (2015)

主要業績:

• Kataoka H., Sample Preparation for Liquid Chromatography (Chapter 1), in Handbooks in Separation Science: Liquid Chromatography 2 nd Edn, Vol. 2, Edited by S. Fanali, P.R. Haddad, C.F. Poole, M.-L Riekkola, (Elsevier: Amsterdam, Netherlands), 1-37 (2017).
• Kataoka H., Mizuno K., Oda E., Saito A., Determination of the oxidative stress biomarker urinary 8-hydroxy-2’-deoxyguanosine by automated on-line in-tube solid-phase microextraction coupled with liquid chromatography?tandem mass spectrometry. J. Chromatogr. B, 1019: 140?146 (2016).
• Kataoka H, Inoue T., Ikekita N., Saito K., Development of exposure assessment method based on the analysis of urinary heterocyclic amines as biomarkers by on-line in-tube solid-phase microextraction coupled with liquid chromatography-tandem mass spectrometry. Anal. Bioanal. Chem., 406: 2171?2178 (2014).
• Kataoka H., Saito K, Kato H., Masuda K., Noninvasive analysis of volatile biomarkers in human emanations for health and early disease diagnosis. Bioanalysis, 5 (11): 1443-1459 (2013).
• Kataoka H., Ishizaki A., Polycyclic Aromatic Hydrocarbons in Foods and Herbal Medicines: Analysis and Occurrence (Chapter 2), in Handbook of Polycyclic Aromatic Hydrocarbons: Chemistry, Occurrence and Health Issues (ISBN 978-1-62257-473-5), Edited by Guilherme C. Bandeira and Henrique E. Meneses (Nova Science Publishers, Inc., New York), 45-82 (2013).

主要業績:

• Suzuki, T., Yasuhara, N., Ueda, T., Inukai, M., Mio, M. (2015) Reaction of acetaldehyde with 5-aminolevulinic acid via dihydropyrazine derivative. Chem. Pharm. Bull. 63, 126-129.
• Suzuki, T., Kitabatake, A., Koide, Y. (2016) Reaction of thymidine with hypobromous acid in phosphate buffer. Chem. Pharm. Bull. 64, 1235-1238.
• Suzuki, T., Ogishi, A., Shinohara, T., Suito, S. (2018) Formation of 8-S-L-cysteinyladenosine from 8-bromoadenosine and cysteine. Chem. Pharm. Bull. 66, 184-187.
• Suzuki, T., Ota, H., Namba, Y., Fujino, T. (2019) Salicylic acid as a photosensitizer for thymidine dimerization induced by UV. Chem. Pharm. Bull. 67, 130-134.
• Suzuki, T., Kumagai, M., Furusawa, M. (2019) Effects of urea on the reactions of nucleosides with hypobromous acid. Chem. Pharm. Bull. 67, 707-712.

その他の業績はresearchmapの研究者情報へ

主要業績:

• 中西　徹　反転授業とアクティブラーニングを通じて実現する新しいキャリア教育「主体的学び」4号90-110,2016主体的学び研究所,東信堂 ISBN 978-4-7989-1365
• 中西　徹　ダックワースがTEDで語る究極の成功因子グリット(GRIT) 「主体的学び」5号142-147,2017主体的学び研究所,東信堂 ISBN 978-4-7989-1471
• 中西　徹　理系、とりわけ生物学から見たリベラルアーツ 「主体的学び」6号 印刷中 2019主体的学び研究所,東信堂
• Nakanishi T. How to make an impression of classical music on students?: Introduction of a trial using musical quotations. "Cases on Kyosei Practice in Music Education." IGI Global 2019, in press
• Nakanishi T. Japan may seek embryo cells from overseas. Nature 405, 882, 2000

主要業績:

• Watanabe, M. (2016) Smoking: additional burden on aging and death. Genes Environment., 38:3.
• 渡辺雅彦、阿蘓寛明、末丸克矢 (2015) 大気微粒子の概要と健康リスク　就実大学薬学雑誌　2, 18-30.
• Nakano, T., Takahashi-Nakaguchi, A, Yamamoto, M. and Watanabe, M. (2014) Pierisins and CARP-1: ADP-ribosylation of DNA by ARTCs in butterflies and shellfish. Curr. Top. Microbiol. Immunol., 384, 127-149.

その他の業績はresearchmapの研究者情報へ

主要業績:

• Otsuka C, Minami I, Oda K, “Hypoxia-inducible genes encoding small EF-hand proteins in rice and tomato”, Biosci Biotech Biochem, 74 (2010)
• Yung CW, Okugawa Y, Otsuka C, Okamoto K, Arimoto S, Loakes D, Negish K, ・Negishi T, ” Influence of neighbouring base sequences on the mutagenesis induced by 7,8-dihydro-8-oxoguanine in yeast”Mutagenesis, 2 (2008)
• Suzuki T, Moriyama K, Loakes D, Otsuka C, Negishi, K,” Template properties of mutagenic cytosine analogues in reverse transcription” Nucleic Acids Res, 34 (2006)

主要業績:

• S. Yamaori, Y. Okushima,?K. Masuda, M. Kushihara, T. Katsu, S. Narimatsu, I. Yamamoto, K. Watanabe, “Structural requirements for potent direct inhibition of human cytochrome P450 1A1 by cannabidiol: Role of pentylresorcinol moiety”, Biological and Pharmaceutical Bulletin, 36(7) , 1197?1203 (2013)
• H. Kataoka, K. Saito, H. Kato,?K. Masuda, “Non-invasive analysis of volatile biomarkers in human emanations for health and early disease diagnosis”, Bioanalysis, 5(11), 1443?1459 (2013)
• H. Kataoka, T. Inoue, K. Saito, H. Kato,?K. Masuda, “Analysis of heterocyclic amines in hair by on-line in-tube solid-phase microextraction coupled with liquid chromatography-tandem mass spectrometry”, Analytica Chimica Acta, 786, 54?60 (2013)
• K. Mayumi, N. Hanioka,?K. Masuda, A. Koeda, S. Naito, A. Miyata, S. Narimatsu, “Characterization of marmoset CYP2B6: cDNA cloning, protein expression and enzymatic functions”, Biochemical Pharmacology, 85(8), 1182?1194 (2013)
• 勝 孝, 駒越圭子,?増田和文, 加藤久登, 井上 剛, “センサーを用いる薬物作用の?in situ?モニタリング”, BUNSEKI KAGAKU, 62(2), 121?130 (2013)

主要業績:

• Taniuchi S, Maeda K,?Kudo T, Takahashi S, Takeuchi S,“Identification of mammalian Pit-1w, possibly involved in spermatogenesis in mice”,?Gen Comp Endocrinol. 173: 289-294 (2011)
• Sutou S, Kunishi M,?Kudo T, Kuwano K, Takagi Y, Sierant M, Sano M, Miyagishi M, “Knockdown of severe acute respiratory syndrome corona virus (SARS-CoV) genes by small interfering RNA (siRNA) using siRNA-expression vectors and synthetic double-stranded RNA (dsRNA) as a model for siRNA design”,?Genes and Environ.?31: 15-23 (2009)
• 高木建次（監訳）『翻訳「バイオエレクトロニクス～理論から応用まで～」』，株式会社NTS，2008〔2，12章を翻訳〕
• Sutou S, Kunishi M,?Kudo T, Pimprapar Wongsrikeao, Miyagishi M, Otoi T, “Knockdown of the bovine prion gene PRNP by RNA interference (RNAi) technology”, BMC Biotech. 7: 44 (2007)
• Murakami I, Takeuchi S,?Kudo T, Sutou S, Takahashi S, “Corticotrophin-releasing hormone or dexamethasone regulate rat proopiomelanocortin transcription through Tpit/Pitx-responsive element in its promoter”, J. Endocrinol. 193: 279-290 (2007)

その他の業績はresearchmapの研究者情報へ

主要業績:

• Yamakawa N, Suzuki K, Yamashita Y, Katsu T, Hanaya K, Shoji M, Sugai T, Mizushima T. Structure-activity relationship of celecoxib and rofecoxib for the membrane permeabilizing activity. , Bioorg. Med. Chem. 22: 2529-2534(2014)
• Yamakawa N, Suemasu S, Watanabe H, Tahara K, Tanaka KI, Okamoto Y, Ohtsuka M, Maruyama T and Mizushima T, “Comparison of pharmacokinetics between loxoprofen and its derivative with lower ulcerogenic activity, fluoro-loxoprofen.” Drug Metab. Pharmacokinet. 28: 118-124 (2013)
• Yamakawa N, Suemasu S, Okamoto Y, Tanaka K, Ishihara T, Asano T, Miyata K, Otsuka M and Mizushima T, “Synthesis and biological evaluation of derivatives of 2-{2-Fluoro-4-[(2-oxocyclopentyl)-methyl]phenyl}propanoic acid: nonsteroidal anti-inflammatory drugs with low gastric ulcerogenic activity”, J. Med. Chem. 55: 5143-5150 (2012)
• Yamakawa N, Suemasu S, Matoyama M, Tanaka K, Katsu T, Miyata K, Okamoto Y, Otsuka M and Mizushima T, “ Synthesis and biological evaluation of loxoprofen derivatives”, Bioorg. Med. Chem. 19: 3299-3311(2011)
• Yamakawa N, Suemasu S, Matoyama M, Kimoto A, Takeda M, Tanaka, K, Ishihara T, Katsu T, Okamoto Y, Otsuka M and Mizushima T, “Properties and synthesis of 2-{2-Fluoro (or Bromo)-4-[(2-oxocyclopentyl)methyl]phenyl}-propanoic acid: nonsteroidal anti-inflammatory drugs with low membrane permeabilizing and gastric lesion-producing activities”, J. Med. Chem. 53: 7879-7882(2010)

主要業績:

• Saito K, Ikeuchi R, Kataoka H. (2012) Determination of ochratoxins in nuts and grain samples by in-tube solid-phase microextraction coupled with liquid chromatography-mass spectrometry. J. Chromatogr. A, 1220: 1-6.
• Saito K, Yagi K, Ishizaki A, Kataoka H. (2010) Determination of anabolic steroids in human urine by automated in-tube solid-phase microextraction coupled with liquid chromatography-mass spectrometry. J. Pharm. Biomed. Anal., 52: 727-733.
• Saito K, Uemura E, Ishizaki A, Kataoka H. (2010) Determination of perfluorooctanoic acid and perfluorooctane sulfonate by automated in-tube solid-phase microextraction coupled with liquid chromatography-mass spectrometry. Anal. Chim. Acta., 658: 141-146.
• Saito K, Okamura K, Kataoka H. (2008) Determination of musty odorants, 2-methylisoborneol and geosmin, in environmental water by headspace solid-phase microextraction and gas chromatography-mass spectrometry. J. Chromatogr. A, 1186: 434-437.

その他の業績はresearchmapの研究者情報へ

主要業績:

• K. Kawakami, P. Li, M. Uraji, T. Hatanaka, H. Ito. “Inhibitory effects of pomegranate extracts on recombinant human maltase-glucoamylase.”, J. food sci., 79, H1848-53 (2014)
• K. Kawakami, H. Nishida, N. Tatewaki, K. Eguchi-Kasai, K. Anzai, T. Eitsuka, T. Konishi, M. Hirayama. “Persimmon ｌeaf ｆlavonols enhance the anti-cancer effect of heavy ion radiotherapy on murine xenograft tumors.” J. Cancer Therapy, 4, 1150-7 (2013)
• K. Kawakami, S. Aketa, H. Sakai, Y. Watanabe, H. Nishida, M. Hirayama. “Antihypertensive and vasorelaxant effects of water-soluble proanthocyanidins from persimmon leaf tea in spontaneously hypertensive rats.” Biosci. Biotechnol. Biochem., 75, 1435-9 (2011)
• K. Kawakami, Y. Shibukura, T. Kanno, T. Furuki, S. Aketa, M. Hirayama. “Identification of 2”-galloylated flavonol 3-O-glycosides accumulating in developing leaves of persimmon (Diospyros kaki Thunb.).” Phytochem. Anal., 22, 403-10 (2011)
• K. Kawakami, S. Aketa, M. Nakanami, M. Hirayama. “Major water-soluble polyphenols, proanthocyanidins, in leaves of persimmon (Diospyros kaki) and their alpha-amylase inhibitory activity.” Biosci. Biotechnol. Biochem., 74, 1380-5. (2010)

主要業績:

• Soeda Y., Yoshikawa M., Almeida OF., Sumioka A., Maeda S., Osada H., Kondoh Y., Saito A., Miyasaka T., Kimura T., Suzuki M., Koyama H., Yoshiike Y., Sugimoto H., Ihara Y., Takashima A. Toxic tau oligomer formation blocked by capping of cysteine residues with 1,2-dihydroxybenzene groups. Nat. Commun., 6:10216 (2015)
• Yoshikawa M., Go S., Suzuki S., Suzuki A., Katori Y., Morlet T., Gottlieb SM., Fujiwara M., Iwasaki K., Strauss KA., Inokuchi J. Ganglioside GM3 is essential for the structural integrity and function of cochlear hair cells. Hum. Mol. Genet., 24, 2796-2807 (2015)
• Go S., Yoshikawa M., Inokuchi J. Glycoconjugates in the mammalian auditory system. J. Neurochem., 116, 756-763 (2011)
• Yoshikawa M., Go S., Takasaki K., Kakazu Y., Oohashi M., Nagafuku M., Kabayama K., Sekimato J., Suzuki S., Takaiwa K., Kimitsuki T., Matsumoto N., Komune S., Kamei D., Saito M., Fujiwara M., Iwasaki K., Inokuchi J. Mice lacking ganglioside GM3 synthase exhibit complete hearing loss due to selective degeneration of the organ of Corti. Proc. Natl. Acad. Sci. USA, 106, 9483-9488 (2009)